5 SIMPLE STATEMENTS ABOUT NUC-7738 EXPLAINED

Must a rise in AST or ALT of thrice the upper limit of usual or better persist, withdrawal of cerivastatin sodium therapy is suggested.Rhabdomyolysis with renal dysfunction secondary to myoglobinuria have been noted with other HMG-CoA reductase inhibitors. This hasn't been reported with cerivastatin sodium to date. Cerivastatin therapy ought to be